WSLHD
Skip navigation
Please use this identifier to cite or link to this item: https://wslhd.intersearch.com.au/wslhdjspui/handle/1/9383
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBadge, H.-
dc.contributor.authorChurches, T.-
dc.contributor.authorNaylor, J. M.-
dc.contributor.authorXuan, W.-
dc.contributor.authorArmstrong, E.-
dc.contributor.authorGray, L.-
dc.contributor.authorFletcher, John P.-
dc.contributor.authorGosbell, I.-
dc.contributor.authorLin, C. C.-
dc.contributor.authorHarris, I. A.-
dc.date.accessioned2024-03-19T04:48:33Z-
dc.date.available2024-03-19T04:48:33Z-
dc.date.issued2024-
dc.identifier.citationScientific Reports 14(1):5955, 2024-
dc.identifier.urihttps://wslhd.intersearch.com.au/wslhdjspui/handle/1/9383-
dc.description.abstractPreventing avoidable venous-thrombo-embolism (VTE) is a priority to improve patient and service outcomes after total hip and total knee arthroplasty (THA, TKA), but compliance with relevant clinical guidelines varies. This study aims to determine the degree to which prophylaxis was compliant with Australian Orthopaedic Association (AOA) VTE prophylaxis guidelines and whether non-compliance is associated with increased risk of VTE. A prospective multi-centre cohort study of adults with osteoarthritis undergoing primary TKA/THA was completed at 19 high-volume public and private hospitals. Data were collected prior to surgery and for one-year post-surgery. Logistic regression was undertaken to explore associations between non-compliance with AOA VTE prophylaxis guidelines and symptomatic 90-day VTE outcomes. Data were analysed for 1838 participants from 19 sites. The rate of non-compliance with all clinical guideline recommendations was 20.1% (N = 369), with 14.1% (N = 259) non-compliance for risk-stratified prophylaxis, 35.8% (N = 658) for duration, and 67.8% (N = 1246) for other general recommendations. Symptomatic VTE was experienced up to 90-days post-surgery by 48 people (2.6%). Overall guideline non-compliance (AOR = 0.93, 95%CI = 0.4 to 1.3, p = 0.86) was not associated with a lower risk of symptomatic 90-day VTE. Results were consistent when people with high bleeding risk were excluded (AOR = 0.94, 95%CI = 0.44 to 2.34, p = 0.89). Non-compliance with the AOA VTE prophylaxis guidelines was not associated with risk of 90-day VTE after arthroplasty. This counterintuitive finding is concerning and necessitates a rigorous review of the AOA VTE prevention clinical guideline.-
dc.titleCompliance with Australian Orthopaedic Association guidelines does not reduce the risk of venous thromboembolism after total hip and knee arthroplasty-
dc.typeJournal Article-
dc.identifier.doihttps://dx.doi.org/10.1038/s41598-024-54916-x-
dc.subject.keywordsVenous Thromboembolism-
dc.subject.keywordsArthroplasty, Replacement, Knee-
dc.subject.keywordsOrthopedics-
dc.subject.keywordsAustralia-
dc.subject.keywordsArthroplasty, Replacement, Hip-
dc.subject.keywordsAnticoagulants-
dc.subject.keywordsPostoperative Complications-
dc.identifier.journaltitleScientific Reports-
dc.contributor.wslhdFletcher, John P.-
dc.identifier.pmid38467650-
dc.identifier.facilityWestmead-
Appears in Collections:Westmead Hospital 2019 - 2024

Files in This Item:
There are no files associated with this item.


Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.